Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Brello Health vs Gala

Gala costs $8.72 less a month, and both sell semaglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Brello Health logo

Brello Health

7.4
★★★★☆3.7/5

Best for: seeing what it charges before you answer any medical questions

Visit Brello Health →
VS
Gala logo

Gala

8.7
★★★★☆4.4/5

Best for: moving between compounded and brand without changing seller

Visit Gala →

If you are choosing between Brello Health and Gala, the first difference is cost: Gala is $8.72 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Gala leads our six-part score, 8.7 to 7.4.

Brello Health vs Gala price

Gala is the cheaper way in: $149 a month against $157.72 a month at Brello Health. That is $8.72 less each month (6% lower), or about $104.64 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Brello Health ($157.72 a month vs $179 a month).

Medications and formats

Both sell semaglutide; only Gala lists tirzepatide.

On format, Brello Health prices compounded injections, while Gala prices compounded injections and brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Gala is the only one of the two with a brand-name price.

Where each one treats patients

Brello Health lists 35 states, and Gala lists 50 states.

They overlap in 34 states. Brello Health alone covers District of Columbia. Gala alone covers 16 states, including Alabama, Arkansas, California and Connecticut.

Pricing

Brello Health

Compounded semaglutide, billed $399 every 11 weeksCompounded
$157.72/mo
semaglutide

Gala

Compounded GLP-1 (all doses)Compounded
$179$129/mo
Save 28% right now
semaglutide

$179/mo on a yearly subscription, all doses included. Gala's FAQ says 'starting at just $199 per month (with a 3-month plan).' A promo page offers 'starting at $129/month with $120 off your first shipment' on monthly, 3-, 6- and 12-month plans. Exact plan prices appear only after the intake questionnaire.

Compounded GLP-1/GIP (all doses)Compounded
$179/mo
tirzepatide

$179/month on a yearly subscription, all doses included; the $120-off-first-shipment promo applies. Tirzepatide plan prices are shown only after intake.

Microdosing GLP-1/GIPCompounded
$149/mo
tirzepatide

$149/month, yearly subscription; 'Low-dose GLP-1/GIP for sustained energy, sleep and metabolic balance.'

Ozempic (brand)Brand-name
$1299/mo
semaglutide

'Ozempic® Brand-name semaglutide $1,299/month' — unchanged. Wegovy pill still 'Coming soon / Pricing at launch' (not a priced row).

What each price covers

Both prices cover the clinician visit and the medication itself.

Gala's price also covers shipping, which Brello Health does not claim.

Brello Health is silent on shipping, lab work and coaching.

Gala is silent on lab work and coaching.

Brello Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Gala

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Gala scores 8.7 and Brello Health 7.4 out of 10.

Brello Health is stronger on trust & safety (8.5 vs 7.5).

Gala is stronger on value (8.7 vs 6.1), effectiveness (10.0 vs 8.5), accessibility (10.0 vs 7.6) and support (7.0 vs 5.5).

User experience is within half a point.

How we score

Brello Health

7.4/10

Overall

Gala

8.7/10

Value25%

6.1A
vs
B
8.7

Effectiveness25%

8.5A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.5A
vs
B
7.5

Accessibility10%

7.6A
vs
B
10.0

Support10%

5.5A
vs
B
7.0

FDA warning letters

Neither Brello Health nor Gala has an FDA warning letter on record with us.

Features & Coverage

FeatureBrello HealthGala
Starting Price$157.72/mo✓$149/mo
Features2 features✓7 features
States Available35✓50
Compounded✓ Yes✓ Yes
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Brello Health

Brello Health is a telehealth wellness platform selling GLP-1 weight management.

Read our full Brello Health review →

About Gala

A yearly subscription is the format: compounded semaglutide and compounded tirzepatide are sold that way, with a cheaper microdosing program beside them and brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware. Providers licensed in every one of the 50 states, plus shipping at no cost, are what the marketing site claims. A Wegovy pill taken orally is flagged as coming soon.

Read our full Gala review →

Pros & Cons

Brello Health

What we like

  • Semaglutide costs $157.72 a month, 14% below the $184 median for compounded semaglutide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication and clinician visits
  • We found no FDA warning letters issued to Brello Health

Watch-outs

  • Serves only 35 states, so check that yours is one of them
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Gala

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $149 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Gala

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Gala

Gala wins this one, 8.7 to 7.4, above all for moving between compounded and brand without changing seller. It also costs $8.72 less each month than Brello Health. Brello Health fits better if seeing what it charges before you answer any medical questions is your priority.

Choose Brello Health if…

You want seeing what it charges before you answer any medical questions and an opening price near $157.72 a month.

Choose Gala if…

You want moving between compounded and brand without changing seller and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.6

Willow

Seeing what it charges before you answer any medical questions

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

Brello Health vs Gala: FAQ

Gala. It starts at $149 a month; Brello Health starts at $157.72 a month, $8.72 more per month.
Yes, both sell semaglutide. Gala adds tirzepatide.
Gala: 50 states against 35, with 34 in common.
Both include the clinician visit and the medication itself. Only Gala includes shipping.
Brello Health has none. Gala has none.
Gala pays us a commission on sign-ups through our links; Brello Health does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.